thimerosal has been researched along with Mucocutaneous Lymph Node Syndrome in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Mutter, J; Yeter, D | 1 |
| Deth, R; Yeter, D | 1 |
2 review(s) available for thimerosal and Mucocutaneous Lymph Node Syndrome
| Article | Year |
|---|---|
Kawasaki's disease, acrodynia, and mercury.
Topics: Acrodynia; Child, Preschool; Dental Amalgam; Ethylmercury Compounds; Female; Genetic Predisposition to Disease; Humans; Infant; Male; Mercury; Methylmercury Compounds; Mucocutaneous Lymph Node Syndrome; Thimerosal; Treatment Outcome; Vaccination | 2008 |
ITPKC susceptibility in Kawasaki syndrome as a sensitizing factor for autoimmunity and coronary arterial wall relaxation induced by thimerosal's effects on calcium signaling via IP3.
Topics: Acrodynia; Autoimmunity; Calcium Signaling; Capillary Permeability; Child; Coronary Vessels; Gene-Environment Interaction; Genetic Predisposition to Disease; Humans; Inositol 1,4,5-Trisphosphate; Mucocutaneous Lymph Node Syndrome; Oxidative Stress; Phosphotransferases (Alcohol Group Acceptor); Polymorphism, Single Nucleotide; Thimerosal | 2012 |